✦ LIBER ✦

Ulcerative Colitis and Crohn's Disease Genetics: More Similar Than We Thought?

✍ Scribed by Miquel Sans; Antoni Castells

Book ID: 119760645
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 79 KB
Volume: 135
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2008.09.054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chimpanzees and bonobos: More similar th

Chimpanzees and bonobos: More similar than we thought?

✍ Jennifer L. Rybak 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB

The Utility of Genetics in Classifying U

The Utility of Genetics in Classifying Ulcerative Colitis and Crohn's Disease Patients

✍ Essers, Jonah B. ;Cole, Elisabeth B. ;Dubinsky, Marla ;Haritunians, Talin ;Korze 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Significant association of appendiceal n

Significant association of appendiceal neoplasms and ulcerative colitis rather than Crohn's disease

✍ Mitsunobu Matsushita; Toshihiro Tanaka; Mika Omiya; Kazuichi Okazaki 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB 👁 1 views

Similar Risk of Depression and Anxiety F

✍ Ananthakrishnan, Ashwin N; Gainer, Vivian S; Cai, Tianxi; Perez, Raul Guzman; Ch 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 226 KB

Distinct and overlapping genetic loci in

Distinct and overlapping genetic loci in crohn's disease and ulcerative colitis: Correlations with pathogenesis

✍ Matti Waterman; Wei Xu; Joanne M. Stempak; Raquel Milgrom; Charles N. Bernstein; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

Prediction of treatment refractoriness i

Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease—do we have reliable markers?

✍ Dr. Cornelia M. Gelbmann 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 962 KB

Treatment refractoriness is a severe problem in the management of patients with ulcerative colitis and Crohn's disease. Despite some promising new therapeutic approaches, corticosteroids are still the preferential primary treatment for moderate to severe Crohn's disease and of severe ulcerative coli